On Monday, June 15, 2020, the U.S. Food and Drug Administration removed the Emergency Authorization Use (EAU) of two malaria drugs to treat COVID-19, saying that they are “unlikely to be effective.”
Both hydroxychloroquine (brand name Plaquenil) and chloroquine were heavily promoted by President Trump after a handful of small, poorly controlled studies showed that they could work in treating the disease.
The FDA reported that further studies had shown that the two drugs were unlikely to be effective in stopping the virus, and that current national treatment guidelines do not recommend using them outside of clinical trials.
Hydroxychloroquine is a low-risk ototoxic drug. Please refer to this feature article for more information.
Recent Posts
Deaths from Falls by Older Adults
As part of an audiologist’s scope of practice, they may assess a patient’s risk for falls. Audiologists, therefore, are likely aware of the hazards related…
Message from the Program Chair: AAA 2026 Call for Abstracts
On behalf of the American Academy of Audiology, I am excited to announce that the AAA 2026 Call for Abstracts opened August 19. As chair…
Plants Can Scream? And Can Animals Hear Them?
Two years ago, a team of scientists from Tel Aviv University were the first to show that plants scream when they are distressed or unhealthy…